Global Egg Protein in Pharmaceuticals Market Segmentation, By Type (Egg White Powder, Egg Yolk Powder, and Whole Egg Protein), Flavour (Flavoured and Regular), Form (Liquid, Powder, and Solid), Function (Binding, Crystallization, Emulsifying, Leavening, Preservatives, and Thickening), Application (Bakery and Confectionery, Dietary Supplements, Feed, Food and Beverages, Ice Cream, Meat Products, Personal Care and Cosmetics, and Protein and Nutritional Bars), Distribution Channel (Convenience Stores, Medical and Drug Stores, Online Store, and Supermarkets/Hypermarkets) – Industry Trends and Forecast to 2031.
Egg Protein in Pharmaceuticals Market Analysis and Size
The egg protein market in pharmaceuticals is experiencing significant growth due to its unique functional properties and high nutritional value. This market benefits from the increasing demand for high-quality protein sources in drug formulations and biologics. Egg protein's ability to act as an effective stabilizer, emulsifier, and carrier enhances the solubility and bioavailability of pharmaceutical compounds, driving its adoption. Additionally, the use of egg protein in vaccine production, particularly for influenza and other viral vaccines, further supports market expansion. Factors such as rising healthcare expenditure, advancements in pharmaceutical technologies, and a growing focus on effective drug delivery systems contribute to the market's positive trajectory.
Egg Protein in Pharmaceuticals Market Size
Global egg protein in pharmaceuticals market size was valued at USD 3.66 billion in 2023 and is projected to reach USD 6.06 billion by 2031, with a CAGR of 6.50% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Report Scope and Market Segmentation
|
Attributes
|
Egg Protein in Pharmaceuticals Key Market Insights
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Egg White Powder, Egg Yolk Powder, and Whole Egg Protein), Flavour (Flavoured and Regular), Form (Liquid, Powder, and Solid), Function (Binding, Crystallization, Emulsifying, Leavening, Preservatives, and Thickening), Application (Bakery and Confectionery, Dietary Supplements, Feed, Food and Beverages, Ice Cream, Meat Products, Personal Care and Cosmetics, and Protein and Nutritional Bars), Distribution Channel (Convenience Stores, Medical and Drug Stores, Online Store, and Supermarkets/Hypermarkets)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of the Middle East and Africa, Brazil, Argentina, Rest of South America.
|
|
Market Players Covered
|
Eat Just, Inc. (U.S.), IntegriCulture Inc. (Japan), Aleph Farms (Israel), AVANTMEATS (China), Believer Meats (U.S.), newprotein (Argentina), BioFood Systems Ltd. (Israel), Meatable (Netherlands), Mission Barns (U.S.), BlueNalu (U.S.), Simple Foods Inc. (U.S.), Shiok Meats (Singapore), CUBIQ FOODS S.L. (Spain)
|
|
Market Opportunities
|
|
Egg Protein in Pharmaceuticals Market Definition
Egg protein in pharmaceuticals refers to the use of proteins derived from eggs, particularly egg whites, in the development and formulation of pharmaceutical products. Egg proteins, known for their high biological value and rich amino acid profile, are utilized for their functional and nutritional properties. In pharmaceuticals, egg proteins are often used as stabilizers, emulsifiers, and carriers in drug formulations. Their ability to enhance the solubility and bioavailability of certain drugs makes them valuable in improving the efficacy of pharmaceutical products.
Egg Protein in Pharmaceuticals Market Dynamics
Drivers
- Effective Stabilization and Emulsification of Egg Proteins
Egg proteins are renowned for their superior stabilizing and emulsifying properties, which make them highly valuable in pharmaceutical applications. In drug formulations, egg proteins function as excellent stabilizers, maintaining the consistency and quality of the product by preventing the separation of ingredients. They also serve as effective emulsifiers, ensuring the uniform dispersion of immiscible substances such as oils and water. This capability is particularly crucial in complex formulations where precise consistency is essential for efficacy. By enhancing the stability and homogeneity of pharmaceutical products, egg proteins contribute to improved drug delivery systems and overall product performance, driving market growth.
- Growing Demand for Vaccines
Egg proteins play a pivotal role in the manufacturing of various vaccines, including those for influenza and other viral infections, where they serve as a medium for the growth of vaccine antigens. The ability of egg proteins to support the cultivation of these antigens ensures the effectiveness and safety of the vaccines. As the global need for biologics continues to rise due to the prevalence of infectious diseases and the expansion of vaccination programs, egg proteins remain integral to the production process. This growing demand for biologics and vaccines thus drives the market for egg proteins.
Opportunities
- Advancements in Pharmaceutical Technologies
New technologies, such as targeted drug delivery systems and novel formulations, often require specialized stabilizers and emulsifiers to enhance their performance and effectiveness. Egg proteins, with their unique functional properties, are well-suited for these advanced applications. As pharmaceutical companies seek to develop more efficient and effective drug delivery solutions, the demand for egg proteins is expected to rise. Innovations in pharmaceutical technologies, including advanced drug delivery systems and formulations, have created significant opportunities for the use of egg proteins.
- Rising Healthcare Expenditure
With healthcare budgets expanding and spending on pharmaceuticals rising, there is a greater emphasis on developing high-quality and effective drug formulations. Egg proteins, known for their superior stabilizing and emulsifying properties, are increasingly being utilized to meet these demands. This rise in healthcare expenditure supports the investment in advanced pharmaceutical products and technologies, further driving the market for egg proteins. As healthcare priorities continue to evolve and expand, the role of egg proteins in ensuring the quality and efficacy of pharmaceutical products becomes increasingly prominent. The increasing global expenditure on healthcare and pharmaceuticals is creating growth opportunities for the egg protein market.
Top of Form
Restraints/Challenges
- Availability of Alternative Proteins
The availability of alternative proteins and stabilizers poses a challenge to the reliance on egg proteins in pharmaceuticals. With the growing interest in plant-based and synthetic alternatives, pharmaceutical companies have more options for stabilizers and emulsifiers that may offer similar or improved functionalities without the potential drawbacks associated with egg proteins. These alternatives can provide solutions for those with allergies or dietary restrictions and may be perceived as more sustainable or cost-effective. As the market for alternative ingredients expands, the demand for egg proteins may be affected, challenging the market growth.
- Allergies to Egg Proteins
Allergies to egg proteins present a significant challenge in the widespread use of these proteins in pharmaceuticals. For individuals with egg allergies, exposure to egg proteins can trigger adverse reactions, which limits their suitability in drug formulations. This constraint necessitates careful consideration and labeling of pharmaceutical products to ensure the safety of consumers. The presence of egg proteins in medications must be managed to avoid allergic reactions, thereby impacting their broader adoption in the market. As a result, the prevalence of egg allergies can restrict the use of egg proteins, affecting their market potential and prompting the exploration of alternative ingredients.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Recent Developments
- In June 2024, U.S. biotech company The EVERY Co. announced a partnership with Canada’s Landish Foods, a leader in nutritional wellness products in North America. Together, they are launching FERMY, a new range of ready-to-mix protein powders for beverages that feature egg white protein derived from precision fermentation
- In December 2023, ingredient innovator EVERY introduced its flagship product, EVERY Egg, the world's first liquid egg made without hens. Created through yeast fermentation, EVERY Egg was launched after nine years of product development by EVERY
Egg Protein in Pharmaceuticals Market Scope
The market is segmented on the basis of type, flavors, form, function, application, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Egg White Powder
- Egg Yolk Powder
- Whole Egg Protein
Flavors
- Flavoured
- Regular
Form
- Solid
- Liquid
- Powder
Function
- Binding
- Crystallization
- Emulsifying
- Leavening
- Preservatives
- Thickening
Application
- Bakery and Confectionery
- Dietary Supplements
- Feed
- Food and Beverages
- Ice Cream
- Meat Products
- Personal Care and Cosmetics
- Protein and Nutritional Bars
Distribution Channel
- Convenience Stores
- Medical and Drug Stores
- Online Store
- Supermarkets/Hypermarkets
Egg Protein in Pharmaceuticals Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country, type, flavors, form, function, application, and distribution channel as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to the growing consumption of protein supplements and an increase in the production of egg protein. The high demand for protein-rich products, coupled with advancements in production technology and infrastructure, supports North America's market leadership.
Asia-Pacific is expected to show significant growth due to the expanding presence of various market players and the rapid development of industrial capabilities in these countries. Increasing awareness of health and nutrition, coupled with rising disposable incomes, is driving demand for egg protein-based pharmaceuticals.
The country section of the report also provides individual market-impacting factors and changes in market regulation that affect the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Egg Protein in Pharmaceuticals Market Share Analysis
The market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the market.
Some of the major market players operating in the market are:
- Eat Just, Inc. (U.S.)
- IntegriCulture Inc. (Japan)
- Aleph Farms (Israel)
- AVANTMEATS (China)
- Believer Meats (U.S.)
- newprotein (Argentina)
- BioFood Systems Ltd. (Israel)
- Meatable (Netherlands)
- Mission Barns (U.S.)
- BlueNalu (U.S.)
- Simple Foods Inc. (U.S.)
- Shiok Meats (Singapore)
- CUBIQ FOODS S.L. (Spain)
SKU-